Soligenix (SNGX) Exchange Rate Effect (2018 - 2024)
Soligenix's (SNGX) quarterly Exchange Rate Effect came in at -$30684.0 in Q4 2024, down 239.35% YoY from $22019.0 in Q1 2024, and down 168.72% on a QoQ basis from $44653.0 in Q3 2024.
Soligenix (SNGX) Exchange Rate Effect (2018 - 2024) Analysis & Trends
Soligenix (SNGX) has 7 years of Exchange Rate Effect data on file, last reported at -$30684.0 in Q4 2024.
- Quarterly Exchange Rate Effect fell 239.35% year-over-year to -$30684.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $14885.0 (down 45.17% YoY) and the FY2024 annual result came in at $14885.0, down 45.17% from the prior year.
- Exchange Rate Effect slipped to -$30684.0 in Q4 2024, from $44653.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $80448.0 in Q1 2022 to a low of -$186677.0 in Q2 2022.
- A 5-year average of $2227.2 and a median of $2973.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 2355.64% — and 2024, when it jumped 5552.14%.
- Tracing SNGX's Exchange Rate Effect over 5 years: stood at $24323.0 in 2020, then tumbled by 129.88% to -$7267.0 in 2021, then surged by 709.51% to $44293.0 in 2022, then slumped by 50.29% to $22019.0 in 2023, then plunged by 239.35% to -$30684.0 in 2024.
- The last three Exchange Rate Effect figures came in at -$30684.0 (Q4 2024), $44653.0 (Q3 2024), and $4052.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -30,684.00 |
| Dec 31, 2024 | -30,684.00 |
| Sep 30, 2024 | 44,653.00 |
| Sep 30, 2024 | 44,653.00 |
| Jun 30, 2024 | 4,052.00 |
| Jun 30, 2024 | 4,052.00 |
| Mar 31, 2024 | -3,136.00 |
| Mar 31, 2024 | -3,136.00 |
| Dec 31, 2023 | 22,019.00 |
| Dec 31, 2023 | 22,019.00 |
| Sep 30, 2023 | -819.00 |
| Sep 30, 2023 | -819.00 |
| Jun 30, 2023 | 1,900.00 |
| Jun 30, 2023 | 1,900.00 |
| Mar 31, 2023 | 4,046.00 |
| Mar 31, 2023 | 4,046.00 |
| Dec 31, 2022 | 44,293.00 |
| Dec 31, 2022 | 44,293.00 |
| Sep 30, 2022 | -37,073.00 |
| Sep 30, 2022 | -37,073.00 |